ITMI20031127A1 - Anticorpi anti-hgf-r e loro uso - Google Patents

Anticorpi anti-hgf-r e loro uso

Info

Publication number: ITMI20031127A1
Authority: IT; Italy
Prior art keywords: antibodies; hgf; relates; hfg; secretes
Prior art date: 2003-06-05

Application number

IT001127A

Other languages

English (en)

Inventor

Maria Giovanna Prat

Original Assignee

Uni Degli Studi Del Piemont E Orientale Am

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-05

Filing date

2003-06-05

Publication date

2004-12-06

2003-06-05 Application filed by Uni Degli Studi Del Piemont E Orientale Am filed Critical Uni Degli Studi Del Piemont E Orientale Am

2003-06-05 Priority to IT001127A priority Critical patent/ITMI20031127A1/it

2003-06-05 Publication of ITMI20031127A0 publication Critical patent/ITMI20031127A0/it

2004-06-01 Priority to DE602004026872T priority patent/DE602004026872D1/de

2004-06-01 Priority to US10/559,305 priority patent/US7556804B2/en

2004-06-01 Priority to AT04741691T priority patent/ATE466031T1/de

2004-06-01 Priority to DK04741691.2T priority patent/DK1641828T3/da

2004-06-01 Priority to PCT/EP2004/050976 priority patent/WO2004108766A2/en

2004-06-01 Priority to EP04741691A priority patent/EP1641828B1/en

2004-06-01 Priority to CA002524329A priority patent/CA2524329A1/en

2004-12-06 Publication of ITMI20031127A1 publication Critical patent/ITMI20031127A1/it

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IT001127A 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso ITMI20031127A1 (it)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
IT001127A ITMI20031127A1 (it)	2003-06-05	2003-06-05	Anticorpi anti-hgf-r e loro uso
DE602004026872T DE602004026872D1 (de)	2003-06-05	2004-06-01	Anti-hgf-r-antikörper und deren verwendung
US10/559,305 US7556804B2 (en)	2003-06-05	2004-06-01	Anti-HGF-R antibodies and their use
AT04741691T ATE466031T1 (de)	2003-06-05	2004-06-01	Anti-hgf-r-antikörper und deren verwendung
DK04741691.2T DK1641828T3 (da)	2003-06-05	2004-06-01	Anti-HGF-R-antistoffer og deres anvendelse
PCT/EP2004/050976 WO2004108766A2 (en)	2003-06-05	2004-06-01	Anti-hgf-r antibodies and their use
EP04741691A EP1641828B1 (en)	2003-06-05	2004-06-01	Anti-hgf-r antibodies and their use
CA002524329A CA2524329A1 (en)	2003-06-05	2004-06-01	Anti-hgf-r antibodies and their use

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT001127A ITMI20031127A1 (it)	2003-06-05	2003-06-05	Anticorpi anti-hgf-r e loro uso

Publications (2)

Publication Number	Publication Date
ITMI20031127A0 ITMI20031127A0 (it)	2003-06-05
ITMI20031127A1 true ITMI20031127A1 (it)	2004-12-06

Family

ID=30131145

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT001127A ITMI20031127A1 (it)	2003-06-05	2003-06-05	Anticorpi anti-hgf-r e loro uso

Country Status (8)

Country	Link
US (1)	US7556804B2 (it)
EP (1)	EP1641828B1 (it)
AT (1)	ATE466031T1 (it)
CA (1)	CA2524329A1 (it)
DE (1)	DE602004026872D1 (it)
DK (1)	DK1641828T3 (it)
IT (1)	ITMI20031127A1 (it)
WO (1)	WO2004108766A2 (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PA8849001A1 (es) *	2008-11-21	2010-06-28	Lilly Co Eli	Anticuerpos de c-met
EP2417160A1 (en)	2009-04-07	2012-02-15	Roche Glycart AG	Bispecific anti-erbb-1/anti-c-met antibodies
PE20120550A1 (es)	2009-04-07	2012-05-21	Roche Glycart Ag	ANTICUERPOS BIESPECIFICOS ANTI-ErbB-3/ANTI-C-MET
KR101671378B1 (ko) *	2009-10-30	2016-11-01	삼성전자 주식회사	ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그의 용도
KR101748707B1 (ko) *	2009-11-27	2017-06-20	삼성전자주식회사	ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
ITTO20091020A1 (it) *	2009-12-21	2011-06-22	Uni Degli Studi Del Piemonte Orientale Ame	"cardiomyocytes anti-apoptotic molecules, products and compositions thereof"
DK3904391T3 (en)	2010-03-10	2024-10-14	Genmab As	Monoclonal antibodies against c-met
CA2816919A1 (en)	2010-11-03	2012-05-10	Anna Hultberg	C-met antibody combinations
WO2013033008A2 (en)	2011-08-26	2013-03-07	Merrimack Pharmaceuticals, Inc.	Tandem fc bispecific antibodies
WO2013043452A1 (en)	2011-09-20	2013-03-28	Eli Lilly And Company	Anti-c-met antibodies
WO2013064700A2 (en)	2011-11-03	2013-05-10	Argen-X B.V.	Chimeric polypeptides and methods of use
KR101910601B1 (ko)	2011-12-22	2018-10-23	삼성전자주식회사	면역원성이 제거된 항 ｃ-Ｍｅｔ 인간화 항체 및 그의 용도
US20150259430A1 (en)	2012-11-05	2015-09-17	Mab Discovery Gmbh	Method for the production of multispecific antibodies
EP2727941A1 (en)	2012-11-05	2014-05-07	MAB Discovery GmbH	Method for the production of multispecific antibodies
CA2902505A1 (en)	2013-03-06	2014-09-12	Merrimack Pharmaceuticals, Inc.	Anti-c-met tandem fc bispecific antibodies
US9168300B2 (en)	2013-03-14	2015-10-27	Oncomed Pharmaceuticals, Inc.	MET-binding agents and uses thereof
EP3122900A1 (en)	2014-03-24	2017-02-01	F. Hoffmann-La Roche AG	Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
WO2016042412A1 (en)	2014-09-16	2016-03-24	Symphogen A/S	Anti-met antibodies and compositions
CN107613974B (zh)	2015-03-16	2021-01-15	塞尔德克斯医疗公司	抗-met抗体及其使用方法
GB201611123D0 (en) *	2016-06-27	2016-08-10	Euremab Srl	Anti met antibodiesand uses thereof
TWI782930B (zh)	2016-11-16	2022-11-11	美商再生元醫藥公司	抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
IT201800000535A1 (it)	2018-01-03	2019-07-03		Procedimenti per la cura del cancro.
KR102433184B1 (ko) *	2018-12-07	2022-08-17	서울대학교 산학협력단	항 c-Met 아고니스트 항체 및 이의 용도
KR102396194B1 (ko) *	2018-12-07	2022-05-10	서울대학교 산학협력단	항 c-Met 아고니스트 항체 및 이의 용도
US11896682B2 (en)	2019-09-16	2024-02-13	Regeneron Pharmaceuticals, Inc.	Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0520158A1 (en)	1991-05-10	1992-12-30	PHARMACIA S.p.A.	Truncated forms of the hepatocyte growth factor (HGF) receptor
US5686292A (en) *	1995-06-02	1997-11-11	Genentech, Inc.	Hepatocyte growth factor receptor antagonist antibodies and uses thereof
US6214344B1 (en) *	1995-06-02	2001-04-10	Genetech, Inc.	Hepatocyte growth factor receptor antagonists and uses thereof
ATE465257T1 (de) *	1996-07-03	2010-05-15	Genentech Inc	Agonisten für den rezeptor des hepatozyten- wachstumsfaktors und deren anwendungen

2003
- 2003-06-05 IT IT001127A patent/ITMI20031127A1/it unknown
2004
- 2004-06-01 DE DE602004026872T patent/DE602004026872D1/de not_active Expired - Lifetime
- 2004-06-01 CA CA002524329A patent/CA2524329A1/en not_active Abandoned
- 2004-06-01 WO PCT/EP2004/050976 patent/WO2004108766A2/en active Search and Examination
- 2004-06-01 AT AT04741691T patent/ATE466031T1/de active
- 2004-06-01 DK DK04741691.2T patent/DK1641828T3/da active
- 2004-06-01 EP EP04741691A patent/EP1641828B1/en not_active Expired - Lifetime
- 2004-06-01 US US10/559,305 patent/US7556804B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2004108766A3 (en)	2005-06-30
US7556804B2 (en)	2009-07-07
WO2004108766A2 (en)	2004-12-16
DE602004026872D1 (de)	2010-06-10
EP1641828B1 (en)	2010-04-28
DK1641828T3 (da)	2010-08-02
CA2524329A1 (en)	2004-12-16
EP1641828A2 (en)	2006-04-05
ATE466031T1 (de)	2010-05-15
US20060140940A1 (en)	2006-06-29
ITMI20031127A0 (it)	2003-06-05

Publication	Publication Date	Title
ITMI20031127A1 (it)	2004-12-06	Anticorpi anti-hgf-r e loro uso
CY1117124T1 (el)	2017-04-05	ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
RS53984B1 (en)	2015-10-30	IP-10 ANTIBODIES AND THEIR USES
NO20071436L (no)	2007-06-08	Humaniserte Anti-5T4 antistoffer og Anti-5T4 antistoff/calicheamicin konjugater
DK1773885T3 (da)	2010-08-16	Humaniserede anti-c-met-antagonister
CY2012019I2 (el)	2015-08-05	Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
EA200401198A1 (ru)	2005-04-28	АНТИТЕЛА ПРОТИВ αvβ6
EA200700083A1 (ru)	2008-02-28	Антитела, направленные против бета-амилоидного пептида, и способы их применения
AR057807A1 (es)	2007-12-19	Formulaciones de anticuerpo anti-cd3
NZ594466A (en)	2012-08-31	Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
CY1110759T1 (el)	2015-06-10	Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
ATE502052T1 (de)	2011-04-15	Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii)
ATE553778T1 (de)	2012-05-15	Für humanes hepcidin spezifische antikörper
UA94211C2 (ru)	2011-04-26	Выделенное полностью человеческое моноклональное cd3 антитело
CL2007003825A1 (es)	2008-05-16	Composicion farmaceutica que comprende un anticuerpo monoclonal humanizado anti-antigeno de diferenciacion leucocitario humano cd6; y su uso para el diagnostico y tratamiento de la leucemia linfocitaria cronica b.
DE60239895D1 (de)	2011-06-09	Humanisierte super-antikörper